Notable Mover: Healthequity Inc’s Trend Up, Especially After Today’s 52-Week High Milestone

Notable Mover: Healthequity Inc's Trend Up, Especially After Today's 52 Week High Milestone

The stock of Healthequity Inc (NASDAQ:HQY) hit a new 52-week high and has $45.29 target or 4.00% above today’s $43.55 share price. The 5 months bullish chart indicates low risk for the $2.60B company. The 1-year high was reported on Nov, 28 by Barchart.com. If the $45.29 price target is reached, the company will be worth $104.00M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 244,967 shares traded hands. Healthequity Inc (NASDAQ:HQY) has risen 69.47% since April 25, 2016 and is uptrending. It has outperformed by 63.46% the S&P500.

Analysts await Healthequity Inc (NASDAQ:HQY) to report earnings on December, 5. They expect $0.09 EPS, up 28.57% or $0.02 from last year’s $0.07 per share. HQY’s profit will be $5.37M for 120.97 P/E if the $0.09 EPS becomes a reality. After $0.14 actual EPS reported by Healthequity Inc for the previous quarter, Wall Street now forecasts -35.71% negative EPS growth.

Healthequity Inc (NASDAQ:HQY) Ratings Coverage

Out of 8 analysts covering HealthEquity Inc (NASDAQ:HQY), 6 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 75% are positive. $40 is the highest target while $27 is the lowest. The $33.67 average target is -22.69% below today’s ($43.55) stock price. HealthEquity Inc has been the topic of 10 analyst reports since August 18, 2015 according to StockzIntelligence Inc. The firm has “Outperform” rating by Leerink Swann given on Monday, April 4. The stock of Healthequity Inc (NASDAQ:HQY) has “Neutral” rating given on Wednesday, September 7 by Robert W. Baird. Barrington Research maintained Healthequity Inc (NASDAQ:HQY) on Tuesday, December 8 with “Outperform” rating. The stock of Healthequity Inc (NASDAQ:HQY) earned “Market Outperform” rating by Avondale on Wednesday, March 23. SunTrust maintained it with “Buy” rating and $40 target price in Wednesday, June 8 report. The stock of Healthequity Inc (NASDAQ:HQY) has “Hold” rating given on Tuesday, October 13 by TheStreet. The company was maintained on Wednesday, March 23 by Barrington Research. JP Morgan reinitiated the shares of HQY in a report on Friday, October 28 with “Overweight” rating. On Wednesday, June 8 the stock rating was maintained by Suntrust Robinson with “Buy”.

According to Zacks Investment Research, “HealthEquity, Inc. is a technology-enabled services platforms that empower consumers to make healthcare saving and spending decisions. The Company’s platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives, and make educated investment choices to grow their tax-advantaged healthcare savings. HealthEquity, Inc. is headquartered in Draper, Utah.”

HQY Company Profile

HealthEquity, Inc., incorporated on October 18, 2002, is a well-known provider of a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Firm is engaged in technology-enabled services platforms that allow clients to make healthcare saving and spending decisions. The Company’s platform provides an ecosystem where clients can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives and make educated investment choices to help in their tax-advantaged healthcare savings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment